Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions
Name:
Marinello.pdf
Size:
55.62Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Marinello, A.Vasseur, D.
Conci, N.
Lindsay, Colin R
Metro, G.
Ferrara, R.
Eisert, A.
Citarella, F.
Fallet, V.
Audugier-Valette, C.
Cousin, S.
Tabbo, F.
Russo, A.
Blanco, A. C.
Gomez, P. I.
Tagliamento, M.
Mezquita, L.
Ponce, S.
Besse, B.
Aldea, M.
Affiliation
Institut Gustave Roussy, Department of Cancer Medicine- Thoracic Unit, Villejuif, France;Issue Date
2022
Metadata
Show full item recordCitation
Marinello A, Vasseur D, Conci N, Lindsay C, Metro G, Ferrara R, et al. Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions. European Journal of Cancer. 2022 Oct;174:S26-S. PubMed PMID: WOS:000876973400062.Journal
European Journal of CancerDOI
10.1016/S0959-8049(22)00871-1Additional Links
https://dx.doi.org/10.1016/S0959-8049(22)00871-1Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/S0959-8049(22)00871-1